Status:
TERMINATED
CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Chikungunya Virus
Eligibility:
All Genders
18-66 years
Phase:
PHASE3
Brief Summary
A severe outbreak of Chikungunya fever has been reported at La Réunion Island (France) in 2005-2006. Chikungunya is a viral disease. Chikungunya virus is an alphavirus transmitted to humans by the bit...
Eligibility Criteria
Inclusion
- Adult patients of more than 18 years and less than 66 years (men and nonpregnant women, without counter-indications) voluntary to take part in of the study, residing at the Reunion Island, having a body weight equal to or higher than 60 kg for a clinical chikungunya disease diagnosed within less than 48 hours.
Exclusion
- Pregnant Women
- More than 66 years old
- body weight less than 60 kg
- without counter-indications to chloroquine
- Renal Insufficiency
- Retinopathy
- Coeliac disease
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00391313
Start Date
May 1 2006
End Date
March 1 2007
Last Update
August 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cellule Coordination Nivachik
Saint-Pierre, Ile de La Reunion, France, 97400